Acquisition expands Day One’s pipeline with clinical-stage antibody drug conjugate (ADC) emiltatug ledadotin (Emi-Le) targeting rare cancer adenoid cystic carcinoma (ACC) BRISBANE, Calif., Jan. 06, ...
The last time I spoke about Day One Biopharmaceuticals, Inc. (DAWN), it was regarding a Seeking Alpha article entitled "Day One Biopharmaceuticals: Mersana Acquisition Ignites March Towards Unmet Need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results